Drreddys Laboratories | RDY - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Bayer EUR 29.71B 863M 2026-06
Canopy Growth CAD 697.59M 60.58M 2026-03
Cipla INR 344.32B 15.13B 2026-03
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Drreddys Laboratories INR 380.46B 376.31B 2026-03
GlaxoSmithKline GBP 17.64B 223M 2026-06
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lonza CHF 9.13B 513M 2025-12
Novartis USD 41.95B 3.02B 2026-06
Pacira USD 671.98M 18.08M 2026-06
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 1.92B 29.2M 2026-06
Richter Gedeon HUF 1.46T 59.22B 2026-03
Sun Pharmaceuticals INR 835.7B 57.5B 2026-03
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06